These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30337050)

  • 41. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
    Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient-reported lung symptoms and quality of life before and after radiation therapy for non-small cell lung cancer: correlation with radiation pneumonitis and functional imaging.
    Farr KP; Khalil AA; Grau C
    Acta Oncol; 2019 Oct; 58(10):1523-1527. PubMed ID: 31315492
    [No Abstract]   [Full Text] [Related]  

  • 43. Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis.
    Kong FM; Ten Haken R; Eisbruch A; Lawrence TS
    Semin Oncol; 2005 Apr; 32(2 Suppl 3):S42-54. PubMed ID: 16015535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy.
    Wijsman R; Dankers FJWM; Troost EGC; Hoffmann AL; van der Heijden EHFM; de Geus-Oei LF; Bussink J
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):434-441. PubMed ID: 28871994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
    Allibhai Z; Taremi M; Bezjak A; Brade A; Hope AJ; Sun A; Cho BC
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1064-70. PubMed ID: 24210082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection.
    Hayes JT; David EA; Qi L; Chen AM; Daly ME
    Clin Lung Cancer; 2015 Sep; 16(5):379-84. PubMed ID: 25737143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer.
    Kimura T; Doi Y; Nakashima T; Imano N; Kawabata H; Nishibuchi I; Okabe T; Kenjo M; Ozawa S; Murakami Y; Nagata Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):778-87. PubMed ID: 26530746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Follow-up after lung stereotactic radiotherapy].
    Waissi W; Noël G; Giraud P
    Cancer Radiother; 2015 Oct; 19(6-7):566-72. PubMed ID: 26337472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity.
    Ong CL; Palma D; Verbakel WF; Slotman BJ; Senan S
    Radiother Oncol; 2010 Dec; 97(3):431-6. PubMed ID: 20971523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lung Size and the Risk of Radiation Pneumonitis.
    Briere TM; Krafft S; Liao Z; Martel MK
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):377-84. PubMed ID: 26675062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.
    Eriguchi T; Takeda A; Sanuki N; Tsurugai Y; Aoki Y; Oku Y; Hara Y; Akiba T; Shigematsu N
    Lung Cancer; 2017 Jul; 109():62-67. PubMed ID: 28577952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review.
    Rodrigues G; Lock M; D'Souza D; Yu E; Van Dyk J
    Radiother Oncol; 2004 May; 71(2):127-38. PubMed ID: 15110445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dosimetric predictors of radiation-induced lung injury.
    Marks LB
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):313-6. PubMed ID: 12243802
    [No Abstract]   [Full Text] [Related]  

  • 54. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy.
    Graham PH; Clark C; Abell F; Browne L; Capp A; Clingan P; De Sousa P; Fox C; Links M
    Australas Radiol; 2006 Aug; 50(4):342-8. PubMed ID: 16884421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy.
    Harder EM; Park HS; Chen ZJ; Decker RH
    Pract Radiat Oncol; 2016; 6(6):e353-e359. PubMed ID: 27156424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer.
    Parashar B; Edwards A; Mehta R; Pasmantier M; Wernicke AG; Sabbas A; Kerestez RS; Nori D; Chao KS
    Am J Clin Oncol; 2011 Apr; 34(2):160-4. PubMed ID: 20498591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
    Choy H; Yee L; Cole BF
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
    Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lung Stereotactic Arc Therapy in Mice: Development of Radiation Pneumopathy and Influence of HIF-1α Endothelial Deletion.
    Lavigne J; Suissa A; Verger N; Dos Santos M; Benadjaoud M; Mille-Hamard L; Momken I; Soysouvanh F; Buard V; Guipaud O; Paget V; Tarlet G; Milliat F; François A
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):279-290. PubMed ID: 30703512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.